Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
| ▸ | GHSR | Q92847 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | VDR | P11473 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6905040 | 1.00 | THRA (0.40) | THRATHRBESR1GHSRKDM4E | |
| SCHEMBL466235 | 1.00 | THRA (0.40) | THRATHRBESR1GHSRKDM4E | |
| SCHEMBL2183919 | 0.97 | THRA (0.40) | THRATHRBESR1GHSRKDM4E | |
| SCHEMBL11213999 | 0.97 | THRA (0.40) | THRATHRBESR1GHSRKDM4E | |
| SCHEMBL9240797 | 0.92 | KDM4E (0.35) | THRATHRBESR1GHSRKDM4E | |
| SCHEMBL11265850 | 0.92 | THRA (0.36) | THRATHRBESR1GHSRSMN1; SMN2 | |
| SCHEMBL12486318 | 0.91 | ESR1 (0.37) | THRATHRBESR1GHSRKDM4E | |
| SCHEMBL12485303 | 0.91 | ESR1 (0.37) | THRATHRBESR1GHSRKDM4E | |
| SCHEMBL10604029 | 0.91 | THRA (0.35) | THRATHRBESR1GHSRKDM4E | |
| SCHEMBL4965655 | 0.90 | THRA (0.40) | THRATHRBESR1GHSRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7956205-B2 | mixing epoxidized vegetable oils with alkyl/aryl substituted phosphite compounds; prevent pungent odor and flavor of rancid fats; oxidation resistance | GALATA CHEMICALS, LLC (US) | 2011-06-07 | — | — | US | claimed |
| US-20080132712-A1 | Peroxide reduction in functionalized vegetable oils | WELLS FARGO BANK, NATIONAL ASSOCIATION, AS AGENT | 2008-06-05 | — | — | US | claimed |
| US-5290747-A | Nylon 6 catalyst system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1994-03-01 | — | — | US | claimed |
| US-9303151-B2 | Stabilizer mixtures for halogen-containing plastics by underwater pelletization | IKA INNOVATIVE KUNSTSTOFFAUFBEREITUNG GMBH & CO. KG (DE) | 2016-04-05 | — | — | US | disclosed |
| US-20150322236-A1 | PVC COMPOSITIONS OF HIGH IMPACT STRENGTH | BASF SE (DE) | 2015-11-12 | — | — | US | disclosed |
| US-9181416-B2 | Stabiliser combinations for halogenated polymers | IKA INNOVATIVE KUNSTSTOFFAUFBEREITUNG GMBH & CO. KG (DE) | 2015-11-10 | — | — | US | disclosed |
| EP-2814884-A1 | PVC COMPOSITIONS OF HIGH IMPACT STRENGTH | BASF SE (DE) | 2014-12-24 | — | — | EP | disclosed |
| WO-2014122075-A1 | LUBRICANT COMPOSITIONS FOR THERMOPLASTIC POLYMERS | BASF SE (DE) | 2014-08-14 | — | — | WO | disclosed |
| WO-2013120792-A1 | PVC COMPOSITIONS OF HIGH IMPACT STRENGTH | BASF SE (DE) | 2013-08-22 | — | — | WO | disclosed |
| US-8506854-B2 | Stabilizer system for halogenated polymers | NABALTEC AG (DE) | 2013-08-13 | — | — | US | disclosed |
| EP-2426167-B1 | Thermally stabilized chlorine containing polymers | LAMBERTI SPA (IT) | 2013-07-17 | — | — | EP | disclosed |
| EP-1461375-A1 | PRESTABILIZATION OF HALOGEN-CONTAINING POLYMERS | Crompton Vinyl Additives GmbH (DE) | 2004-09-29 | — | — | EP | disclosed |
| US-20040132875-A1 | Chlorate-containing stabilizer system with nitrogen-containing synergists for stabilizing halogen-containing polymers | CHEMTURA VINYL ADDITIVES GMBH (DE) | 2004-07-08 | — | — | US | disclosed |
| US-20040054043-A1 | Stabilizer system for stabilizing polymers that contain halogen | WACHOVIA CAPITAL FINANCE CORPORATION (NEW ENGLAND) | 2004-03-18 | — | — | US | disclosed |
| WO-2003048232-A1 | PRESTABILIZATION OF HALOGEN-CONTAINING POLYMERS | CROMPTON VINYL ADDITIVES GMBH (DE) | 2003-06-12 | — | — | WO | disclosed |
| US-6013703-A | AN ORGANIC ZINC COMPOUND AND AN ORGANIC ALUMINIUM, SODIUM OR POTASSIUM COMPOUND IN COMBINATION WITH A STERICALLY HINDERED AMINES AS THE STABILIZER MIXTURE FOR POLYVINYL CHLORIDE; LEAD-FREE | WITCO VINYL ADDITIVES GMBH (DE) | 2000-01-11 | — | — | US | disclosed |
| US-5804622-A | STERIC HINDRANCE | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-09-08 | — | — | US | disclosed |
| US-5298594-A | Charging caprolactam, water and alkali metal hypophosphite catalyst, purging air, heating to form prepolymer, charging prepolymer with cocatalyst, heating by raising temperature | CHINESE PETROCHEMICAL DEVELOPMENT CORP. (TW) | 1994-03-29 | — | — | US | disclosed |
| US-5298598-A | Preparation of polyamide with mixture of phosphorus catalysts | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1994-03-29 | — | — | US | disclosed |
| US-5290747-A | Nylon 6 catalyst system | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1994-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132712-A1 | Peroxide reduction in functionalized vegetable oils | GPX4, OXSR1, HAO2 | THRA 643/4885THRB 748/4885ESR1 2036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.